28130638|t|Marginal vitamin A deficiency facilitates Alzheimer's pathogenesis.
28130638|a|Deposition of amyloid beta protein (Abeta) to form neuritic plaques in the brain is the unique pathological hallmark of Alzheimer's disease (AD). Abeta is derived from amyloid beta precursor protein (APP) by beta- and gamma-secretase cleavages and turned over by glia in the central nervous system (CNS). Vitamin A deficiency (VAD) has been shown to affect cognitive functions. Marginal vitamin A deficiency (MVAD) is a serious and widespread public health problem among pregnant women and children in developing countries. However, the role of MVAD in the pathogenesis of AD remains elusive. Our study showed that MVAD is approximately twofold more prevalent than VAD in the elderly, and increased cognitive decline is positively correlated with lower VA levels. We found that MVAD, mostly prenatal MVAD, promotes beta-site APP cleaving enzyme 1 (BACE1)-mediated Abeta production and neuritic plaque formation, and significantly exacerbates memory deficits in AD model mice. Supplementing a therapeutic dose of VA rescued the MVAD-induced memory deficits. Taken together, our study demonstrates that MVAD facilitates AD pathogenesis and VA supplementation improves cognitive deficits. These results suggest that VA supplementation might be a potential approach for AD prevention and treatment.
28130638	0	29	Marginal vitamin A deficiency	Disease	MESH:D010437
28130638	42	53	Alzheimer's	Disease	MESH:D000544
28130638	104	109	Abeta	Gene	11820
28130638	119	127	neuritic	Disease	MESH:D058225
28130638	188	207	Alzheimer's disease	Disease	MESH:D000544
28130638	209	211	AD	Disease	MESH:D000544
28130638	214	219	Abeta	Gene	351
28130638	236	266	amyloid beta precursor protein	Gene	351
28130638	373	393	Vitamin A deficiency	Disease	MESH:D014802
28130638	395	398	VAD	Disease	MESH:D014802
28130638	446	475	Marginal vitamin A deficiency	Disease	MESH:D010437
28130638	477	481	MVAD	Disease	MESH:D010437
28130638	548	553	women	Species	9606
28130638	613	617	MVAD	Disease	MESH:D010437
28130638	641	643	AD	Disease	MESH:D000544
28130638	683	687	MVAD	Disease	MESH:D010437
28130638	733	736	VAD	Disease	MESH:D014802
28130638	767	784	cognitive decline	Disease	MESH:D003072
28130638	821	823	VA	Chemical	-
28130638	846	850	MVAD	Disease	MESH:D010437
28130638	868	872	MVAD	Disease	MESH:D010437
28130638	883	914	beta-site APP cleaving enzyme 1	Gene	23821
28130638	916	921	BACE1	Gene	23821
28130638	932	937	Abeta	Gene	11820
28130638	953	968	neuritic plaque	Disease	MESH:D058225
28130638	1010	1025	memory deficits	Disease	MESH:D008569
28130638	1029	1031	AD	Disease	MESH:D000544
28130638	1038	1042	mice	Species	10090
28130638	1080	1082	VA	Chemical	-
28130638	1095	1099	MVAD	Disease	MESH:D010437
28130638	1108	1123	memory deficits	Disease	MESH:D008569
28130638	1169	1173	MVAD	Disease	MESH:D010437
28130638	1186	1188	AD	Disease	MESH:D000544
28130638	1206	1208	VA	Chemical	-
28130638	1234	1252	cognitive deficits	Disease	MESH:D003072
28130638	1281	1283	VA	Chemical	-
28130638	1334	1336	AD	Disease	MESH:D000544
28130638	Association	MESH:D058225	23821
28130638	Positive_Correlation	MESH:D058225	11820
28130638	Association	11820	351
28130638	Positive_Correlation	MESH:D010437	23821
28130638	Association	11820	23821
28130638	Positive_Correlation	MESH:D010437	11820
28130638	Association	MESH:D000544	11820

